Douglas C. Monsour Drug and Medical Device Litigation Law Blog on Lawyers.com

Avandia (rosiglitazone) is an FDA approved drug used in the treatment of Type 2 diabetes, a serious condition affecting approximately 20 million Americans. Since its approval in 1992, the drug has been prescribed to as many as 10 million Americans, thousands of whom--according to one expert--have suffered Avandia-related heart problems.

Over the years, Avandia has been linked to various side effects including:

• Congestive heart failure, edema, and fluid retention
• Liver toxicity
• Low blood pressure

The findings published by the New England Journal of Medicine, however, are raising new concerns about the extent of the heart risks associated with Avandia. In an analysis of 40 studies and more than 28,000 patients, researchers found that those taking Avandia were between 30 to 40 percent more likely to suffer heart attack and heart-related death than those taking a placebo or other diabetes drug. As of May 2007, the FDA said data analyses were ongoing to confirm the risks.

Avandia lawsuits have resulted because of the serious side effects that have been reported including congestive heart failure, hepatitis, and liver failure. When Rezulin diabetes drug was recalled Avandia was intended to replace it as a safer alternative, however the consumer group Public Citizen never recognized Avandia to be a safe alternative. If you would like more information on your legal rights and options regarding Avandia litigation, please contact us. 

About Us:

The Monsour Law Firm handles personal injury cases, such as serious motor vehicle accidents; catastrophic injuries; and products liability cases, such as pharmaceutical injures and defective products. At the Monsour Law Firm, our practice emphasizes recovery of damages on behalf of persons and surviving families, who have suffered severe or disabling injuries involving Avandia, Gadolinium, Dilantin, and Stevens Johnson Syndrome.  Click here to read more about the firm…

Currently Douglas C. Monsour is serving as lead lawyer in a large group of Fen-Phen cases against American Home Products/Wyeth involving heart valve damage and pulmonary hypertension caused by the diet drugs Pondimin and Redux. He is also representing numerous Vioxx victims against Merck, Zyprexa victims against Eli Lilly, and Bextra Victims against Pfizer. He is also handling several wrongful death cases involving asbestos, electrocution, defective products, and the trucking industry. In addition, he is handling several severe injury cases involving the trucking industry, chemical manufacturers, insurance carriers, side effects of Avandia (Rosiglitazone), and drunk drivers.  Click here to read more about Doug…